Prognostic Value of Measurable Residual Disease Monitoring by Next-Generation Sequencing before and after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

The authors collected samples before and after allogeneic hematopoietic stem cell transplantation from two independent prospective cohorts and investigated the prognostic impact of amplicon-based next-generation sequencing-based assessment.